 | • レポートコード：D0GIR-01256 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、術後悪心嘔吐（PONV）の世界市場を広く調査・分析し、今後の市場展望をまとめております。術後悪心嘔吐（PONV）の種類別市場規模（セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他、非薬理学的治療）、用途別市場規模（病院薬局、オンライン薬局、小売薬局、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Acacia Pharma、Eisai、Ani Pharmaceuticals、F. Hoffmann-La Roche、Helsinn Holding、Novartis、GlaxoSmithKline、Sanofi、Camurus、Merck ・地域別グローバル市場分析 2015年-2020年 ・術後悪心嘔吐（PONV）の北米市場（アメリカ、カナダ、メキシコ） ・術後悪心嘔吐（PONV）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・術後悪心嘔吐（PONV）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・術後悪心嘔吐（PONV）の南米市場（ブラジル、アルゼンチン） ・術後悪心嘔吐（PONV）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：セロトニン拮抗薬、ステロイド、ドーパミン拮抗薬、NK-1受容体拮抗薬、その他、非薬理学的治療 ・用途別分析：病院薬局、オンライン薬局、小売薬局、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Postoperative Nausea and Vomiting (PONV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Postoperative Nausea and Vomiting (PONV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Postoperative Nausea and Vomiting (PONV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Postoperative Nausea and Vomiting (PONV) market has been segmented into:
Serotonin Antagonists
Steroids
Dopamine Antagonists
NK-1 Receptor Antagonists
Others
Non-pharmacologic Treatment
By Application, Postoperative Nausea and Vomiting (PONV) has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies and Drug Stores
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Postoperative Nausea and Vomiting (PONV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Postoperative Nausea and Vomiting (PONV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Postoperative Nausea and Vomiting (PONV) market.
The report offers in-depth assessment of the growth and other aspects of the Postoperative Nausea and Vomiting (PONV) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Postoperative Nausea and Vomiting (PONV) Market Share Analysis
Postoperative Nausea and Vomiting (PONV) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Postoperative Nausea and Vomiting (PONV) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Postoperative Nausea and Vomiting (PONV) sales, revenue and market share for each player covered in this report.
The major players covered in Postoperative Nausea and Vomiting (PONV) are:
Acacia Pharma
Eisai
Ani Pharmaceuticals
F. Hoffmann-La Roche
Helsinn Holding
Novartis
GlaxoSmithKline
Sanofi
Camurus
Merck
Table of Contents
1 Postoperative Nausea and Vomiting (PONV) Market Overview
1.1 Product Overview and Scope of Postoperative Nausea and Vomiting (PONV)
1.2 Classification of Postoperative Nausea and Vomiting (PONV) by Type
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type in 2019
1.2.3 Serotonin Antagonists
1.2.4 Steroids
1.2.5 Dopamine Antagonists
1.2.6 NK-1 Receptor Antagonists
1.2.7 Others
1.2.8 Non-pharmacologic Treatment
1.3 Global Postoperative Nausea and Vomiting (PONV) Market by Application
1.3.1 Overview: Global Postoperative Nausea and Vomiting (PONV) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Global Postoperative Nausea and Vomiting (PONV) Market by Regions
1.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Postoperative Nausea and Vomiting (PONV) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Postoperative Nausea and Vomiting (PONV) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Acacia Pharma
2.1.1 Acacia Pharma Details
2.1.2 Acacia Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Acacia Pharma SWOT Analysis
2.1.4 Acacia Pharma Product and Services
2.1.5 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eisai
2.2.1 Eisai Details
2.2.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eisai SWOT Analysis
2.2.4 Eisai Product and Services
2.2.5 Eisai Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Ani Pharmaceuticals
2.3.1 Ani Pharmaceuticals Details
2.3.2 Ani Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Ani Pharmaceuticals SWOT Analysis
2.3.4 Ani Pharmaceuticals Product and Services
2.3.5 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche SWOT Analysis
2.4.4 F. Hoffmann-La Roche Product and Services
2.4.5 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Helsinn Holding
2.5.1 Helsinn Holding Details
2.5.2 Helsinn Holding Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Helsinn Holding SWOT Analysis
2.5.4 Helsinn Holding Product and Services
2.5.5 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GlaxoSmithKline SWOT Analysis
2.7.4 GlaxoSmithKline Product and Services
2.7.5 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sanofi SWOT Analysis
2.8.4 Sanofi Product and Services
2.8.5 Sanofi Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Camurus
2.9.1 Camurus Details
2.9.2 Camurus Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Camurus SWOT Analysis
2.9.4 Camurus Product and Services
2.9.5 Camurus Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Postoperative Nausea and Vomiting (PONV) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Postoperative Nausea and Vomiting (PONV) Players Market Share
3.2.2 Top 10 Postoperative Nausea and Vomiting (PONV) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Regions
4.2 North America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
4.3 Europe Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
4.5 South America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
5 North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries
5.1 North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2015-2020)
5.2 USA Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
5.3 Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
5.4 Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
6 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Countries
6.1 Europe Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2015-2020)
6.2 Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
6.3 UK Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
6.4 France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
6.5 Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
6.6 Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Countries
7.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2015-2020)
7.2 China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
7.3 Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
7.4 Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
7.5 India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
8 South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries
8.1 South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2015-2020)
8.2 Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
8.3 Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Postoperative Nausea and Vomiting (PONV) by Countries
9.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
9.3 UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
9.4 Egypt Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
9.5 South Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Postoperative Nausea and Vomiting (PONV) Revenue and Market Share by Type (2015-2020)
10.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Type (2019-2024)
10.3 Serotonin Antagonists Revenue Growth Rate (2015-2025)
10.4 Steroids Revenue Growth Rate (2015-2025)
10.5 Dopamine Antagonists Revenue Growth Rate (2015-2025)
10.6 NK-1 Receptor Antagonists Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
10.8 Non-pharmacologic Treatment Revenue Growth Rate (2015-2025)
11 Global Postoperative Nausea and Vomiting (PONV) Market Segment by Application
11.1 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2015-2020)
11.2 Postoperative Nausea and Vomiting (PONV) Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Online Pharmacies Revenue Growth (2015-2020)
11.5 Retail Pharmacies and Drug Stores Revenue Growth (2015-2020)
12 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast (2021-2025)
12.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Forecast (2021-2025)
12.2 Global Postoperative Nausea and Vomiting (PONV) Market Forecast by Regions (2021-2025)
12.3 North America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
12.4 Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
12.6 South America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Postoperative Nausea and Vomiting (PONV) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Acacia Pharma Corporate Information, Location and Competitors
Table 6. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Major Business
Table 7. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 8. Acacia Pharma SWOT Analysis
Table 9. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 10. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Eisai Corporate Information, Location and Competitors
Table 12. Eisai Postoperative Nausea and Vomiting (PONV) Major Business
Table 13. Eisai Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2018-2019)
Table 14. Eisai SWOT Analysis
Table 15. Eisai Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 16. Eisai Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Ani Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Major Business
Table 19. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 20. Ani Pharmaceuticals SWOT Analysis
Table 21. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 22. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 24. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Major Business
Table 25. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 26. F. Hoffmann-La Roche SWOT Analysis
Table 27. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 28. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Helsinn Holding Corporate Information, Location and Competitors
Table 30. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Major Business
Table 31. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 32. Helsinn Holding SWOT Analysis
Table 33. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 34. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis Corporate Information, Location and Competitors
Table 36. Novartis Postoperative Nausea and Vomiting (PONV) Major Business
Table 37. Novartis Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 38. Novartis SWOT Analysis
Table 39. Novartis Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 40. Novartis Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. GlaxoSmithKline Corporate Information, Location and Competitors
Table 42. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Major Business
Table 43. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 44. GlaxoSmithKline SWOT Analysis
Table 45. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 46. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Sanofi Corporate Information, Location and Competitors
Table 48. Sanofi Postoperative Nausea and Vomiting (PONV) Major Business
Table 49. Sanofi Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 50. Sanofi SWOT Analysis
Table 51. Sanofi Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 52. Sanofi Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Camurus Corporate Information, Location and Competitors
Table 54. Camurus Postoperative Nausea and Vomiting (PONV) Major Business
Table 55. Camurus Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 56. Camurus SWOT Analysis
Table 57. Camurus Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 58. Camurus Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Merck Corporate Information, Location and Competitors
Table 60. Merck Postoperative Nausea and Vomiting (PONV) Major Business
Table 61. Merck Postoperative Nausea and Vomiting (PONV) Total Revenue (USD Million) (2017-2018)
Table 62. Merck SWOT Analysis
Table 63. Merck Postoperative Nausea and Vomiting (PONV) Product and Solutions
Table 64. Merck Postoperative Nausea and Vomiting (PONV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Players (2015-2020)
Table 66. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players (2015-2020)
Table 67. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2015-2020)
Table 69. North America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2015-2020)
Table 70. North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Table 71. Europe Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Postoperative Nausea and Vomiting (PONV) Revenue by Countries (2015-2020)
Table 74. South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Table 77. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) by Type (2015-2020)
Table 78. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type (2015-2020)
Table 79. Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Type (2021-2025)
Table 80. Global Postoperative Nausea and Vomiting (PONV) Revenue by Application (2015-2020)
Table 81. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2015-2020)
Table 82. Global Postoperative Nausea and Vomiting (PONV) Revenue Forecast by Application (2021-2025)
Table 83. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Postoperative Nausea and Vomiting (PONV) Picture
Figure 2. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type in 2019
Figure 3. Serotonin Antagonists Picture
Figure 4. Steroids Picture
Figure 5. Dopamine Antagonists Picture
Figure 6. NK-1 Receptor Antagonists Picture
Figure 7. Others Picture
Figure 8. Non-pharmacologic Treatment Picture
Figure 9. Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application in 2019
Figure 10. Hospital Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Retail Pharmacies and Drug Stores Picture
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2019
Figure 22. Global Top 10 Players Postoperative Nausea and Vomiting (PONV) Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions (2015-2020)
Figure 26. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Regions in 2018
Figure 27. North America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 28. Europe Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 30. South America Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 32. North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Figure 33. North America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2019
Figure 34. USA Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 35. Canada Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 37. Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2019
Figure 39. Germany Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 40. UK Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 41. France Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 42. Russia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 43. Italy Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2019
Figure 46. China Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 47. Japan Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 48. Korea Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 49. India Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 51. South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Figure 52. South America Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2019
Figure 53. Brazil Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 58. UAE Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Postoperative Nausea and Vomiting (PONV) Revenue and Growth Rate (2015-2020)
Figure 61. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type (2015-2020)
Figure 62. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Type in 2019
Figure 63. Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Type (2021-2025)
Figure 64. Global Serotonin Antagonists Revenue Growth Rate (2015-2020)
Figure 65. Global Steroids Revenue Growth Rate (2015-2020)
Figure 66. Global Dopamine Antagonists Revenue Growth Rate (2015-2020)
Figure 67. Global NK-1 Receptor Antagonists Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Non-pharmacologic Treatment Revenue Growth Rate (2015-2020)
Figure 70. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application (2015-2020)
Figure 71. Global Postoperative Nausea and Vomiting (PONV) Revenue Share by Application in 2019
Figure 72. Global Postoperative Nausea and Vomiting (PONV) Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 75. Global Retail Pharmacies and Drug Stores Revenue Growth Rate (2015-2020)
Figure 76. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Postoperative Nausea and Vomiting (PONV) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
Figure 80. Europe Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
Figure 82. South America Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Postoperative Nausea and Vomiting (PONV) Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
化学療法による吐き気・嘔吐（CINV）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Chemotherapy-Induced Nausea and Vomiting (CINV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. T…- メニエール病治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Meniere's Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere's Disease Dru…
- 心臓リハビリテーションサービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cardiac Rehabilitation Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- 獣医疼痛管理の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Veterinary Pain Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1215.5 million by 2025, from USD 1025.5 million in 2019. The Veterinar…
- 制吐薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antiemetics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 4511.4 million by 2025, from USD 3927.3 million in 2019. The Antiemetics market repor…